Isosorbide DiNitrate Effect on Hemodynamic Profile, Liver Stiffness, and Exercise Tolerance in Fontan Circulation (The NEET Clinical Trial)
- 21 April 2023
- journal article
- research article
- Published by Springer Nature in Pediatric Cardiology
- Vol. 45 (7) , 1389-1397
Abstract
After Fontan operation, decreased venous capacitance and venoconstriction are adaptive mechanisms to maintain venous return and cardiac output. The consequent higher venous pressure may adversely impact end-organ function, exercise capacity and result in worse clinical outcomes. This pilot study evaluated the safety and effect of isosorbide dinitrate (ISDN), a venodilator, on exercise capacity, peripheral venous pressure (PVP), and liver stiffness in patients with Fontan circulation. In this prospective single-arm trial, 15 individuals with Fontan circulation were evaluated at baseline and after 4 weeks of therapeutic treatment with ISDN. Primary aims were to assess the safety of ISDN and the effect on maximal exercise. We also aimed to evaluate the effect of ISDN on ultrasound-assessed liver stiffness, markers of submaximal exercise, and PVP at rest and peak exercise. Repeated measures t-tests were used to assess change in variables of interest in response to ISDN. Mean age was 23.5 ± 9.2 years (range 11.2–39.0 years), and 10/15 (67%) were male. There was no statistically significant change in peak VO2 (1401 ± 428 to 1428 ± 436 mL/min, p = 0.128), but VO2 at the anaerobic threshold increased (1087 ± 313 to 1115 ± 302 mL/min, p = 0.03). ISDN was also associated with a lower peak exercise PVP (22.5 ± 4.5 to 20.6 ± 3.0 mmHg, p = 0.015). Liver stiffness was lower with ISDN, though the difference was not statistically significant (2.3 ± 0.4 to 2.1 ± 0.5 m/s, p = 0.079). Of the patients completing the trial, mild headache was common (67%), but there were no major adverse events. Treatment with ISDN for 4 weeks is well-tolerated in patients with a Fontan circulation. ISDN is associated with an increase in VO2 at anaerobic threshold, lower peak PVP, and a trend toward lower liver stiffness. Larger, longer duration studies will be necessary to define the impact of ISDN on clinical outcomes in the Fontan circulation. Clinical Trial Registration: URL: https://clinicaltrials.gov. Unique identifier: NCT04297241.Keywords
All Related Versions
This publication has 36 references indexed in Scilit:
- The Precarious State of the Liver After a Fontan Operation: Summary of a Multidisciplinary SymposiumPediatric Cardiology, 2012
- Hydralazine and Isosorbide Dinitrate in Heart FailureCirculation, 2011
- Exercise Testing Identifies Patients at Increased Risk for Morbidity and Mortality Following Fontan SurgeryCongenital Heart Disease, 2011
- Predictors of morbidity and mortality in contemporary Fontan patients: results from a multicenter study including cardiopulmonary exercise testing in 321 patientsEuropean Heart Journal, 2010
- Peripheral Vascular Adaptation and Orthostatic Tolerance in Fontan PhysiologyCirculation, 2009
- A Cross-Sectional Study of Exercise Performance During the First 2 Decades of Life After the Fontan OperationJACC, 2008
- Venous Function and Central Venous PressureAnesthesiology, 2008
- Hepatic changes in the failing Fontan circulationHeart, 2006
- Cardiopulmonary response to exercise in patients with the Fontan circulationCardiology in the Young, 2005
- Post-exercise heart rate, blood pressure and oxygen uptake dynamics in pediatric patients with Fontan circulationInternational Journal of Cardiology, 2005